+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Asthma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030- Product Image
Asthma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030- Product Image
New

Asthma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • PDF Icon

    Report

  • 185 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5941542
Free Webex Call
10% Free customization
Description Jump to:

Combination Therapy is the fastest growing segment, North America is the largest market globally

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Asthma Therapeutics Market will grow from USD 27.52 Billion in 2024 to USD 34.3 Billion by 2030 at a 3.74% CAGR. Asthma therapeutics encompass a range of pharmaceutical medications and treatment modalities designed to manage and alleviate the symptoms of asthma, a chronic respiratory condition characterized by airway inflammation and narrowing. The market's growth is primarily driven by the escalating global prevalence of asthma, particularly in urbanized regions, and the increasing awareness regarding disease management.

Key Market Drivers

The increasing global asthma prevalence significantly propels the demand for therapeutics. A growing number of individuals worldwide are diagnosed with this chronic respiratory condition, necessitating long-term management and various treatment interventions. This expanding patient population inherently broadens the market for existing medications and drives the need for new therapeutic developments. Factors such as urbanization, increased exposure to environmental allergens, and lifestyle changes contribute to the rising incidence of asthma across diverse demographics.

Key Market Challenges

The high cost associated with advanced biologic therapies represents a significant challenging factor for the global asthma therapeutics market. This elevated pricing directly impacts patient access, particularly in diverse healthcare systems where reimbursement policies or individual financial capacities may be restrictive. Consequently, a substantial portion of the patient population requiring these advanced treatments may face barriers to obtaining them, thereby limiting the overall market penetration and expansion of these innovative therapies.

Key Market Trends

This trend transforms asthma management via real-time data and enhanced medication adherence. Digital health platforms and smart inhalers, with sensors, monitor usage and technique, directly improving treatment efficacy. Over 35 million people in the U.S. lived with a chronic lung condition in 2023, as reported by the American Lung Association in September 2024, highlighting the need for these solutions. Such integration enables personalized adjustments and better patient-provider communication. For example, Adherium announced in April 2024 that its Hailie Smartinhaler received FDA clearance for AstraZeneca’s Airsupra and Breztri inhalers, providing real-time medication usage insights. These advancements drive demand for technologically integrated therapeutics.

Key Market Players Profiled:

  • Teva Pharmaceutical Industries Ltd.
  • GSK plc.
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd.
  • AstraZeneca plc.
  • Boehringer Ingelheim International GmbH
  • Sanofi S.A.
  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • Sunovion Pharmaceuticals, Inc.

Report Scope:

In this report, the Global Asthma Therapeutics Market has been segmented into the following categories:

By Drug Class:

  • Anti-inflammatory
  • Combination Therapy
  • Bronchodilators

By Product:

  • Inhalers
  • Nebulizers

By Route of Administration:

  • Oral
  • Inhaled
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Asthma Therapeutics Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:
  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Asthma Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class (Anti-inflammatory, Combination Therapy, Bronchodilators)
5.2.2. By Product (Inhalers, Nebulizers)
5.2.3. By Route of Administration (Oral, Inhaled, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Asthma Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.2. By Product
6.2.3. By Route of Administration
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Asthma Therapeutics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Class
6.3.1.2.2. By Product
6.3.1.2.3. By Route of Administration
6.3.2. Canada Asthma Therapeutics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Class
6.3.2.2.2. By Product
6.3.2.2.3. By Route of Administration
6.3.3. Mexico Asthma Therapeutics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Class
6.3.3.2.2. By Product
6.3.3.2.3. By Route of Administration
7. Europe Asthma Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Product
7.2.3. By Route of Administration
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Asthma Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Class
7.3.1.2.2. By Product
7.3.1.2.3. By Route of Administration
7.3.2. France Asthma Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Class
7.3.2.2.2. By Product
7.3.2.2.3. By Route of Administration
7.3.3. United Kingdom Asthma Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Class
7.3.3.2.2. By Product
7.3.3.2.3. By Route of Administration
7.3.4. Italy Asthma Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Class
7.3.4.2.2. By Product
7.3.4.2.3. By Route of Administration
7.3.5. Spain Asthma Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Class
7.3.5.2.2. By Product
7.3.5.2.3. By Route of Administration
8. Asia Pacific Asthma Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Product
8.2.3. By Route of Administration
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Asthma Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Class
8.3.1.2.2. By Product
8.3.1.2.3. By Route of Administration
8.3.2. India Asthma Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Class
8.3.2.2.2. By Product
8.3.2.2.3. By Route of Administration
8.3.3. Japan Asthma Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Class
8.3.3.2.2. By Product
8.3.3.2.3. By Route of Administration
8.3.4. South Korea Asthma Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Class
8.3.4.2.2. By Product
8.3.4.2.3. By Route of Administration
8.3.5. Australia Asthma Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Class
8.3.5.2.2. By Product
8.3.5.2.3. By Route of Administration
9. Middle East & Africa Asthma Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Product
9.2.3. By Route of Administration
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Asthma Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Class
9.3.1.2.2. By Product
9.3.1.2.3. By Route of Administration
9.3.2. UAE Asthma Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Class
9.3.2.2.2. By Product
9.3.2.2.3. By Route of Administration
9.3.3. South Africa Asthma Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Class
9.3.3.2.2. By Product
9.3.3.2.3. By Route of Administration
10. South America Asthma Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Product
10.2.3. By Route of Administration
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Asthma Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Class
10.3.1.2.2. By Product
10.3.1.2.3. By Route of Administration
10.3.2. Colombia Asthma Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Class
10.3.2.2.2. By Product
10.3.2.2.3. By Route of Administration
10.3.3. Argentina Asthma Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Class
10.3.3.2.2. By Product
10.3.3.2.3. By Route of Administration
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Asthma Therapeutics Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Teva Pharmaceutical Industries Ltd.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. GSK plc.
15.3. Merck & Co., Inc.
15.4. F. Hoffmann-La Roche Ltd.
15.5. AstraZeneca plc.
15.6. Boehringer Ingelheim International GmbH
15.7. Sanofi S.A.
15.8. Koninklijke Philips N.V.
15.9. Becton, Dickinson and Company
15.10. Sunovion Pharmaceuticals, Inc.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

  • Teva Pharmaceutical Industries Ltd.
  • GSK plc.
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd.
  • AstraZeneca plc.
  • Boehringer Ingelheim International GmbH
  • Sanofi S.A.
  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • Sunovion Pharmaceuticals, Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 27.52 Billion
Forecasted Market Value ( USD ) by 2030 $ 34.3 Billion
Compound Annual Growth Rate3.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Asthma Therapeutics Market Size, Share, Trends and Forecast by Drug Class, Product Type, Treatment Type, Route of Administration, and Region, 2025-2033 - Product Image

Asthma Therapeutics Market Size, Share, Trends and Forecast by Drug Class, Product Type, Treatment Type, Route of Administration, and Region, 2025-2033

  • Report
  • 136 Pages
  • Global
From
Asthma Therapeutics Market Report 2025 - Product Image

Asthma Therapeutics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Asthma Therapeutics - Global Strategic Business Report - Product Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Asthma Therapeutics Market - Global Forecast 2025-2032 - Product Image

Asthma Therapeutics Market - Global Forecast 2025-2032

  • Report
  • 197 Pages
  • Global
From
COPD and Asthma Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Anti-Inflammatory, Bronchodilators), Device/Product (Inhalers), Technology/Software, Indication, Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

COPD and Asthma Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Anti-Inflammatory, Bronchodilators), Device/Product (Inhalers), Technology/Software, Indication, Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.